Of the eight globally listed exchange traded products that track the Nasdaq Biotechnology Index (the gold standard of biotech indexes), this newly minted ETF is a practical option for investors – and the least expensive. Here’s how the fund is setting itself apart. CLICK HERE.
This Biotech ETF Is New, Practical & Cost-Effective
- by Ashley Hayes
![](https://stockinvestornews.com/wp-content/uploads/2023/04/002-Unsplash-Water-.jpeg)
Tags:Biotech ETFBiotech IndexesCost-Effective InvestmentFundsInvestNasdaq Biotechnology IndexStock Market